Seth Lederman
Company: CEO & Chairman Tonix Pharmaceuticals
Job title: Co-Founder
Bio:
Seth Lederman is founder and CEO of Tonix. Prior to founding Tonix, Dr. Lederman founded Vela, Targent, and Validus Pharmaceuticals. Targent was acquired by Spectrum Pharmaceuticals, which marketed Targent’s levoleucovorin as Fusilev® for advanced colorectal cancer. Dr. Lederman was on the faculty of Columbia University medical school from 1985 – 2017 (Asst. Prof 1988 – 1996 and then Assoc. Prof with tenure.) Dr. Lederman earned an AB from Princeton in Chemistry cum laude in 1979 and an MD from Columbia University’s College of Physicians and Surgeons in 1983. Dr. Lederman trained in internal medicine and rheumatology at Columbia’s Presbyterian Hospital.
Seminars:
Live Q&A 12:20 pm
day: Day Two
Developing a PTSD Therapeutic – Phase 3 Clinical Development 11:55 am
Targeting disturbed sleep in PTSD to facilitate recovery Role of time-since-trauma in treatment responsiveness Trimodal mechanism of action of cyclobenzaprine; enhancement by dynamic diurnal pharmacokinetic deliveryRead more
day: Day Two